CAI — Caris Life Sciences Inc
In 2026 Q2, 5 of the 140 tracked hedge funds reported a position in Caris Life Sciences Inc (CAI), worth $47.19M combined. Over the quarter 4 opened or added, 0 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Duquesne | $33.76M | 0.78% | NO CHANGE |
| Renaissance | $10.12M | 0.01% | +26.3% |
| CastleKnight | $2.36M | 0.09% | +222.2% |
| Emerald | $542.49K | 0.01% | +192.1% |
| IMC | $412.50K | 0.00% | +79.2% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.